Search results
Results from the WOW.Com Content Network
Eli Lilly (NYSE: LLY) Q4 2024 Earnings Call Feb 06, 2025, 10:00 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants. ... and Eli Lilly wasn’t one of them. The 10 stocks ...
Eli Lilly reported fourth quarter and full-year earnings for 2024 on Thursday.The results largely beat Wall Street estimates and sent the stock up about 2%. But the company missed on GLP-1 sales. ...
Eli Lilly And Co (NYSE:LLY) will announce its fourth-quarter 2024 financial results and 2025 financial guidance on February 6. As per data from Benzinga Pro, the Wall Street estimates sales of $13 ...
For 2025, the Indianapolis drugmaker expects adjusted earnings to range between $22.50 and $24 with revenue falling between $58 billion and $61 billion. Analysts expect earnings of $22.77 per share on $58.8 billion in revenue. Eli Lilly and Co. shares climbed about 2% Thursday morning to $857.40 while broader trading indexes started the day mixed.
Thanks for joining us for Eli Lilly and Company's Q2 2024 earnings call. I'm Joe Fletcher, senior vice president of investor relations. And joining me on today's call are Dave Ricks, Lilly's ...
Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast. Sales of Lilly’s top-selling product, the diabetes treatment Mounjaro, jumped 60% to $3.53 billion in the final quarter of 2024 while its obesity ...
Eli Lilly (NYSE: LLY) stock inched 2.5% higher through 9:50 a.m. ET Thursday after beating on the top and bottom lines in this morning's Q4 earnings report. Heading into the report, analysts ...
Eli Lilly missed Wall Street's revenue expectations in its third quarter earnings released Wednesday morning, which sent shares down more than 6%.The drugmaker also slashed its profit guidance and ...